Fresenius Medical Care AG (FMS) Net Income towards Common Stockholders (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Net Income towards Common Stockholders for 17 consecutive years, with $479.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders rose 68.72% year-over-year to $479.6 million; the TTM figure through Dec 2025 stood at $783.0 million (up 9.23% YoY), while the FY2025 annual figure was $1.5 billion, up 50.55% from the prior year.
• Net Income towards Common Stockholders came in at $479.6 million for Q4 2025 at Fresenius Medical Care AG, up from $1.1 in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $479.6 million in Q4 2025, with the low at $0.55 in Q1 2025.
• Average Net Income towards Common Stockholders over 5 years is $202.6 million, with a median of $197.9 million recorded in 2023.
• Across the five-year window, Net Income towards Common Stockholders surged 71.55% in 2024 and slumped 100.0% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $262.0 million in 2021, then sank by 45.87% to $141.8 million in 2022, then gained by 16.84% to $165.7 million in 2023, then soared by 71.55% to $284.2 million in 2024, then soared by 68.72% to $479.6 million in 2025.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $479.6 million, $1.1, and $303.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.